Walker Marlan's Insider Trades & SAST Disclosures
Walker Marlan's most recent trade in TherapeuticsMD Inc was a trade of 3,467 Common Stock done . Disclosure was reported to the exchange on Feb. 18, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Walker Marlan.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| TherapeuticsMD Inc | Marlan D. Walker | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 3,467 | 66,032 (0%) | 0% | 0 | Common Stock | |
| TherapeuticsMD Inc | Marlan D. Walker | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 3,467 | 0 | - | - | Performance Stock Units | |
| TherapeuticsMD Inc | Marlan D. Walker | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 2,311 | 68,343 (0%) | 0% | 0 | Common Stock | |
| TherapeuticsMD Inc | Marlan D. Walker | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 2,311 | 0 | - | - | Restricted Stock Units | |
| TherapeuticsMD Inc | Marlan D. Walker | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 1,733 | 1,733 | - | - | Restricted Stock Units | |
| TherapeuticsMD Inc | Marlan D. Walker | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 1,733 | 70,846 (0%) | 0% | 0 | Common Stock | |
| TherapeuticsMD Inc | Marlan D. Walker | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 770 | 69,113 (0%) | 0% | 0 | Common Stock | |
| TherapeuticsMD Inc | Marlan D. Walker | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 770 | 0 | - | - | Restricted Stock Units | |
| TherapeuticsMD Inc | Walker Marlan | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Dec 2023 | 70,000 | 81,615 (0%) | 0% | 0 | Common Stock | |
| TherapeuticsMD Inc | Marlan Walker | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Dec 2023 | 70,000 | 0 | - | - | Restricted Stock Units | |
| TherapeuticsMD Inc | Marlan Walker | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 2.31 per share. | 05 Dec 2023 | 14,500 | 67,115 (0%) | 0% | 2.3 | 33,496 | Common Stock |
| TherapeuticsMD Inc | Walker Marlan | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 2.24 per share. | 05 Dec 2023 | 4,550 | 62,565 (0%) | 0% | 2.2 | 10,187 | Common Stock |
| TherapeuticsMD Inc | Marlan Walker | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Apr 2023 | 1,734 | 3,466 | - | - | Restricted Stock Units | |
| TherapeuticsMD Inc | Marlan Walker | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Apr 2023 | 1,734 | 12,307 (0%) | 0% | 0 | Common Stock | |
| TherapeuticsMD Inc | Marlan Walker | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Apr 2023 | 1,010 | 0 | - | - | Restricted Stock Units | |
| TherapeuticsMD Inc | Marlan Walker | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Apr 2023 | 1,010 | 14,041 (0%) | 0% | 0 | Common Stock | |
| TherapeuticsMD Inc | Marlan Walker | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 3.64 per share. | 12 Apr 2023 | 692 | 11,615 (0%) | 0% | 3.6 | 2,518 | Common Stock |
| TherapeuticsMD Inc | Marlan Walker | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2023 | 70,000 | 70,000 | - | - | Restricted Stock Units | |
| TherapeuticsMD Inc | Marlan Walker | Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2022 | 716 | 5,969 (0%) | 0% | 0 | Common Stock | |
| TherapeuticsMD Inc | Marlan Walker | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2022 | 260,000 | 260,000 | - | - | Performance Stock Units | |
| TherapeuticsMD Inc | Marlan Walker | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Mar 2022 | 260,000 | 260,000 | - | - | Restricted Stock Units | |
| TherapeuticsMD Inc | Marlan Walker | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Mar 2022 | 260,000 | 260,000 | - | - | Restricted Stock Units | |
| TherapeuticsMD Inc | Marlan Walker | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Mar 2022 | 230,000 | 0 | - | - | Restricted Stock Units | |
| TherapeuticsMD Inc | Marlan Walker | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Mar 2022 | 230,000 | 258,908 (0%) | 0% | - | Common Stock | |
| TherapeuticsMD Inc | Marlan Walker | General Counsel | Other type of transaction at price $ 0.00 per share. | 29 Sep 2021 | 150,000 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| TherapeuticsMD Inc | Marlan Walker | General Counsel | Other type of transaction at price $ 0.00 per share. | 29 Sep 2021 | 120,000 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| TherapeuticsMD Inc | Marlan Walker | General Counsel | Other type of transaction at price $ 0.00 per share. | 29 Sep 2021 | 100,000 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| TherapeuticsMD Inc | Marlan Walker | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Sep 2021 | 57,797 | 57,797 | - | - | Restricted Stock Units | |
| TherapeuticsMD Inc | Marlan Walker | General Counsel | Other type of transaction at price $ 0.00 per share. | 29 Sep 2021 | 25,000 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| TherapeuticsMD Inc | Marlan Walker | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2021 | 346,667 | 346,667 | - | - | Performance Stock Units | |
| TherapeuticsMD Inc | Marlan Walker | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2021 | 173,333 | 173,333 | - | - | Restricted Stock Units | |
| TherapeuticsMD Inc | Marlan Walker | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 May 2021 | 50,500 | 101,000 | - | - | Restricted Stock Units | |
| TherapeuticsMD Inc | Marlan Walker | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 May 2021 | 50,500 | 50,500 (0%) | 0% | - | Common Stock | |
| TherapeuticsMD Inc | Marlan Walker | General Counsel | Sale of securities on an exchange or to another person at price $ 1.04 per share. | 10 May 2021 | 21,592 | 28,908 (0%) | 0% | 1.0 | 22,456 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges